Aripiprazole Tablet
Product Images NDC 50090-6063

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 50090-6063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Aripiprazole Figure 1)

Figure 1 (Aripiprazole Figure 1)
The text appears to be a table showing the effect of different drugs on Aripiprazole, and their PK Aipprazol Fad Change and 50% CI. The drugs are categorized based on whether they inhibit or induce CYP3As, inhibit CYP2D6, are gastric acid blockers, or are a general other drug. The values in the table show the change relative to a reference without interacting drugs.*
FDA Label Image

Figure 2 (Aripiprazole Figure 2)

Figure 2 (Aripiprazole Figure 2)
This text appears to be a table showing the effect of different drugs on aripiprazole. The drugs listed include gastric acid blockers, valproate, and oxazepam. The table shows the percentage change in the effectiveness of aripiprazole when taken in combination with these other drugs, as compared to when it is taken alone. The text is not very clear and seems to have some errors, but this is the best interpretation that can be made.*
FDA Label Image

Figure 3 (Aripiprazole Figure 3)

Figure 3 (Aripiprazole Figure 3)
FDA Label Image

Figure 4 (Aripiprazole Figure 4)

Figure 4 (Aripiprazole Figure 4)
This is a description of different special populations in a study. It includes information on the impact of gender and hepatic impairment on AUC, as well as information on renal impairment. There is also a chart showing the Aviprazcie Food Change and 50% CI relative to reference.*
FDA Label Image

Figure 5 (Aripiprazole Figure 5)

Figure 5 (Aripiprazole Figure 5)
Not available. The provided text seems to be a random collection of characters, abbreviations, and incomplete words without any clear context or meaning.*
FDA Label Image

Figure-6 (Aripiprazole Figure 6)

Figure-6 (Aripiprazole Figure 6)
FDA Label Image

Figure-7 (Aripiprazole Figure 7)

Figure-7 (Aripiprazole Figure 7)
FDA Label Image

Figure-8 (Aripiprazole Figure 8)

Figure-8 (Aripiprazole Figure 8)
This appears to be a table displaying the results of a study comparing the relapse rates of two drugs, "ARFPRAZOLE" and "PucEsq," on a certain number of subjects. The table shows the number of subjects at risk and the proportion of those who experienced relapse. However, the text seems to contain errors and non-meaningful characters, making it difficult to interpret. It is not available.*
FDA Label Image

Aripiprazole Chemical Structure (Aripiprazole Structure)

Aripiprazole Chemical Structure (Aripiprazole Structure)
FDA Label Image

Label Image (Lbl500906063)

Label Image (Lbl500906063)
The package contains 30 tablets of 20mg of the medication "ARIPRAZOLE". The product number is "6344-0" and it was stored at a temperature of 7 degrees Celsius. The other characters ("1me, zos" and "0050-s") are not clear and therefore their meaning is "not-available".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.